Rocket Pharmaceuticals Stock (NASDAQ:RCKT), Quotes and News Summary

Q: What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rocket Pharmaceuticals Stock (NASDAQ: RCKT) stock price, news, charts, stock research, profile.

Open	$23.500
Close	-
Volume / Avg.	76.053K / 725.546K
Day Range	23.320 - 23.930
52 Wk Range	14.890 - 32.525
Market Cap	$2.151B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	15.14%
Days to Cover	18.84

Recent News

Merit Medical Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 40 points on Monday.

Lisa Levin

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

Investors are on the hunt for undervalued, under followed and emerging stocks. Retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

Chris Katje

Dow Turns Lower; KULR Technology Group Shares Plummet

U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling 100 points on Wednesday. The Dow traded down 0.29% to 34,545.66 while the NASDAQ rose 0.22% to 13,803.43. The S&P 500, also rose, gaining, 0.01% to 4,462.11.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Rocket Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the developme...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rocket Pharmaceuticals (RCKT) stock?

You can purchase shares of Rocket Pharmaceuticals (NASDAQ: RCKT) through any online brokerage.

View our list of the best stock brokerages.

Who are Rocket Pharmaceuticals's (RCKT) competitors?

Other companies in Rocket Pharmaceuticals’s space includes: Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Fusion Pharmaceuticals (NASDAQ:FUSN), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).

What is the target price for Rocket Pharmaceuticals (RCKT) stock?

The latest price target for Rocket Pharmaceuticals (NASDAQ: RCKT) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 53.00 expecting RCKT to rise to within 12 months (a possible 122.97% upside). 20 analyst firms have reported ratings in the last year.

Current Stock Price for Rocket Pharmaceuticals (RCKT)?

The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $23.77 last updated Today at April 18, 2024 at 11:31 AM EDT.

Does Rocket Pharmaceuticals (RCKT) pay a dividend?

There are no upcoming dividends for Rocket Pharmaceuticals.

When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?

Rocket Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Rocket Pharmaceuticals (RCKT) going to split?

There is no upcoming split for Rocket Pharmaceuticals.

What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-